CTRI/2010/091/001350已完成1 期
An open labeled, non- comparative single center study to assess the bioavailability and safety of nano-atropine sulfate by dry powder inhalation in healthy human volunteers
Defence R&D Organisation0 个研究点目标入组 6 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male human volunteers, 18-65 years of age, body weight of 50-70kg.
- •2. May include mild smokers who are willing to abstain smoking on the day of test
排除标准
- •1. Volunteers who are unwilling to give informed consent.
- •2. Volunteers taking any medication or having URI/lung infection at time of study.
- •3. Volunteers with significant dyspnea or cough due to any cause.
- •4. Volunteers having any contraindications like increased intraocular pressure (IOP), lung disease, unstable cardiac rhythm, tachycardia etc
- •5. Volunteers who have compromised lung function due to any cause
- •6. Volunteers who have any medical condition which in the judgment of the investigator may render them in appropriate for participation in the trial
研究者
相似试验
已完成
1 期
A clinical trial to assess the bioavailability and safety of atropine sulfate injected by sublingual submucosal injection in healthy human volunteers for nerve gas poisoningCTRI/2010/091/001352Defence R&D Organisation6
已完成
1 期
A clinical trial to assess the bioavailability and safety of atropine sulfate by intranasal drops in healthy human volunteers for nerve gas poisoningCTRI/2010/091/001347Defence R&D Organisation6
已完成
1 期
A clinical trial to assess the efficacy and safety of atropine sulfate by inhalation in healthy human volunteers for nerve gas poisoningCTRI/2010/091/001351Defence R&D Organisation6
尚未招募
3 期
single-dose clinical study evaluating efficacy and safety of standard intramuscular preparation of Paracetamol available in the market for the management of feverCTRI/2018/10/016216Troikaa Pharmaceuticals Limited
招募中
不适用
Phase I/II clinical trial to Assess the Maximum Tolerated Dose (MTD), Safety and Efficacy of BEY1107 in Monotherapy and in Combination With Gemcitabine in Patient with Locally Advanced or Metastatic Pancreatic CancerNeoplasmsKCT0003140BeyondBio Inc.75